Additional Details
-
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
The University of Kansas Medical Center Research InstituteKansas City KS. 66160View Details -
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Mayo Clinic of FloridaJacksonville FL. 32224View Details -
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Bend Memorial ClinicBend OR. 97701View Details -
Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
UCLA Health Westwood Medical PlazaWestwood CA. 90095View Details -
Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
University of New Mexico Health Sciences CenterAlbuquerque NM. 87131View Details -
Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Valley Advanced Lung Diseases InstituteFresno CA. 93720View Details -
Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Pulmonary Associates of Richmond, Inc.Richmond VA. 23230View Details -
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
UCLA Health Westwood Medical PlazaWestwood CA. 90095View Details -
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
USA001Santa Barbara CA. 93105View Details -
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
USA003Bend OR. 97701View Details -
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
USA008Richmond VA. 23230View Details -
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
USA006Naples FL. 34102View Details -
Nucleoside Therapy in Patients With Telomere Biology Disorders
Boston Childrens HospitalBoston MA. 02115View Details -
Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
Snyder Building 480 Ray C. Hunt DriveCharlottesville VA. 22908View Details -
A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment
Renstar Medical ResearchOcala FL. 34470View Details -
A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment
Kelowna Respirology & Allergy ResearchKelowna BC. V1Y 3H5View Details -
A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment
University of Missouri Health SystemColumbia MO. 65212View Details -
A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment
Banner - University Medical Center TucsonTucson AZ. 85724View Details -
A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment
Centre Hospitalier de l'Universite de Montreal (CHUM)Montreal QC. H2X 0A9View Details